Cargando…
Optimizing neoadjuvant radiotherapy for resectable and borderline resectable pancreatic cancer using protons
Approximately 25% of patients diagnosed with pancreatic cancer present with non-metastatic resectable or borderline resectable disease. Unfortunately, the cure rate for these “curable” patients is only in the range of 20%. Local-regional failure rates may exceed 50% after margin-negative, node-negat...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Baishideng Publishing Group Inc
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6783690/ https://www.ncbi.nlm.nih.gov/pubmed/31602289 http://dx.doi.org/10.4240/wjgs.v11.i7.303 |